NuSirt Health launches LEUSIX supplement for weight management and metabolic health

TAGS

NuSirt Health has unveiled its latest innovation, LEUSIX, a dietary supplement designed to aid weight management and improve cardiometabolic health. Now available on Amazon, the supplement offers a natural, evidence-backed alternative for individuals exploring options beyond GLP-1 drugs.

The supplement’s formulation combines leucine, an essential amino acid, with Vitamin B6 in a patented ratio. This proprietary blend is based on NuSirt’s discovery of leucine’s ability to amplify the benefits of nutrients like Vitamin B6 and compounds like resveratrol and berberine. Clinical trials have demonstrated significant results, including weight loss, reduced waist circumference, and improved metabolic markers.

See also  Evening Primrose Oil : Medicinal Uses

The company noted that participants in trials reported an average weight loss of 9% over 24 weeks while preserving lean body mass. Additionally, waistlines shrank by approximately two inches within the first month, and daily caloric burn increased by around 300 calories. Markers of oxidative and inflammatory stress improved, with insulin resistance decreasing by nearly 40%.

Unlike GLP-1 drugs, which suppress appetite and may cause side effects like nausea, LEUSIX works by targeting metabolic pathways. It redirects energy consumption from fat to skeletal muscle, preserving muscle mass while promoting fat loss. NuSirt Health emphasized that the supplement could appeal to individuals seeking a natural first step or a solution to maintain results after transitioning off GLP-1 medications.

See also  Unlocking the medicinal secrets of Alexandrian Laurel: A comprehensive insight

LEUSIX has also shown potential for managing obesity in pets. A study on overweight dogs revealed a 22% reduction in body weight over 12 weeks without requiring caloric restrictions. This finding underscores the supplement’s adaptability for diverse needs.

NuSirt Health, operating as NuSirt Sciences, Inc., focuses on evidence-based solutions for global cardiometabolic health. Alongside LEUSIX, the company is developing TRIPLN, a combination therapy incorporating metformin, sildenafil, and leucine, for conditions like diabetes and hypertension.

See also  South Korea approves Morinaga Milk's B. breve B-3 strain for weight management

LEUSIX is available now on Amazon. While clinical trials highlight its benefits, users are advised to consult healthcare professionals before starting the supplement. Individual results may vary, and the product is not FDA-approved for diagnosing or treating any disease.


Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

CATEGORIES
TAGS
Share This

COMMENTS

Wordpress (0)
Disqus ( )